Walleye Capital
NVCR icon

Walleye Capital’s NovoCure NVCR Stock Holding History

Walleye Capital’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$1.29K – 4967
2025
Q3 		$1.29K Hold
100
– – ﹤0.01% 4369
2025
Q2 		$1.78K Buy
+100
New +$1.74K ﹤0.01% 4391
2025
Q1 		– Sell
-7,400
Closed -$221K – 4854
2024
Q4 		$221K Sell
7,400
-600
-8% -$12.7K ﹤0.01% 3676
2024
Q3 		$125K Buy
8,000
+900
+13% +$16.3K ﹤0.01% 4291
2024
Q2 		$122K Buy
7,100
+7,000
+7,000% +$123K ﹤0.01% 4620
2024
Q1 		$1.56K Sell
100
-1,500
-94% -$22.1K ﹤0.01% 5285
2023
Q4 		$23.9K Sell
1,600
-4,500
-74% -$60.2K ﹤0.01% 4447
2023
Q3 		$98.5K Buy
6,100
+1,900
+45% +$54.8K ﹤0.01% 3949
2023
Q2 		$174K Sell
4,200
-8,500
-67% -$528K ﹤0.01% 3160
2023
Q1 		$764K Buy
12,700
+12,300
+3,075% +$983K 0.01% 1359
2022
Q4 		$29.3K Sell
400
-7,500
-95% -$564K ﹤0.01% 2612
2022
Q3 		$600K Buy
+7,900
New +$616K 0.01% 1341
2019
Q4 		– Sell
-7,100
Closed -$531K – 2116
2019
Q3 		$531K Buy
7,100
+600
+9% +$48K 0.03% 720
2019
Q2 		$411K Buy
6,500
+5,100
+364% +$258K 0.05% 583
2019
Q1 		$67K Buy
+1,400
New +$67.4K 0.01% 1143

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Walleye Capital's NVCR Position: Q1 2026 in Review

Walleye Capital sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 11,676 shares — an estimated $151K sold.

Walleye Capital first reported a position in NVCR in Q1 2019 and held it in 16 quarters. The position peaked at $2.8M in Q3 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Walleye Capital reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 11,676 NovoCure shares in Q1 2026, an estimated $151K.
  • Walleye Capital first reported a position in NovoCure in Q1 2019 and held it in 16 quarters.
  • Walleye Capital's NovoCure position peaked at $2.8M in Q3 2025.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.